For at efterkomme retningslinjen "Note for Guidance on Evaluation of Medicinal Products Indicated for Treatment of Bacterial Infections" (CPMP/ EWP/ 558/ 95 rev. 1) accepterede ansøgeren, at det ansøgte produktresumé bliver opdateret i rette tid til, at tærskelværdier fra EUCAST kan indgå.
In order to comply with the NfG on Evaluation of Medicinal Products Indicated for Treatment of Bacterial Infections (CPMP/ EWP/ 558/ 95 rev.1), the applicant accepted that proposed SPC should be updated in due time to include EUCAST breakpoints.